Patient Information Leaflet. Package leaflet: Information for the patient. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution . Learn about BYETTA, the BYETTA Pen. in patients with prior severe hypersensitivity reactions to exenatide or to any of the product components. PRODUCT MONOGRAPH. BYETTA® exenatide injection. µg/mL. mL prefilled pen (60 doses of 5 µg/dose) and. mL prefilled pen.

Author: Yozshugul JoJom
Country: Jordan
Language: English (Spanish)
Genre: Love
Published (Last): 24 October 2006
Pages: 477
PDF File Size: 2.99 Mb
ePub File Size: 14.97 Mb
ISBN: 160-1-77410-791-6
Downloads: 11283
Price: Free* [*Free Regsitration Required]
Uploader: Kigalkis

Major The manufacturer of insulin detemir recommends initiating therapy with insulin detemir at 10 units subcutaneously once packkage when combining with a GLP-1 receptor agonist such as exenatide.

Welcome to!

The mechanism of the interaction is not known although it may be due to delayed gastric emptyingnor is the clinical significance of this potential interaction. The site you are about to visit is maintained by a third party who is solely responsible for its contents.

It is acceptable for the injections to be in the same body region but the injections should NOT be adjacent to each other.

According to OBRA, the use of antidiabetic medications should include monitoring e. Exenatide should not be administered after ijsert meal. The amino acid sequence of mecasermin rh-IGF-1 is approximately 50 percent homologous to insulin and cross binding with either receptor is possible. Taking an oral contraceptive at least 1 hour before an incretin mimetic injection should reduce the risk of an effect on contraceptive or hormonal absorption.

Postmarketing reports of altered renal function, including increased serum creatinine, renal impairment, worsened packave renal failure, and acute renal failure, sometimes requiring hemodialysis and kidney transplantation.


Even if the disposable needle is changed, sharing packge result in transmission of hepatitis viruses, HIV, or other blood-borne pathogens. You are encouraged to report negative side effects of prescription drugs to the FDA.

The main risk factors for impaired glucose tolerance due to corticosteroids are the dose of steroid and duration of treatment. If a patient chooses to ingest alcohol, they should bjetta their blood glucose frequently.

In patients with concomitant type1 diabetes mellitus, octreotide is likely to affect glucose regulation, and insulin requirements may be reduced. Moderate The risk of hypoglycemia is increased when exenatide is used in combination byetts insulins or insulin secretagogues such as the sulfonylureas.

Diabetic patients should be monitored for potential hypoglycemic reactions while on linezolid. Following a single subcutaneous injection, exenatide is released from the suspension microspheres over approximately 10 weeks.

Some patients may require adjustment to their hypoglycemic medications over time.

Minor Increased frequency of blood glucose monitoring may be required when clonidine is given with antidiabetic agents. These may be symptoms of pancreatitis. It is not known whether monitoring serum calcitonin or performing thyroid ultrasounds will diminish human risk of thyroid C-cell tumors.

This effect may lead to hypoglycemia acutely, followed by hyperglycemia with prolonged pentamidine therapy. Because blood glucose may be lowered by the use of chromium, patients who are on antidiabetic agents may need dose adjustments.

Minor Carbonic anhydrase inhibitors may alter blood sugar. Symptomatic hypoglycemia, which may be severe, has been reported in type 1 diabetic patients.


Ethinyl Estradiol; Norethindrone; Ferrous fumarate: If a breast-feeding infant experiences an adverse effect related to a maternally ingested drug, healthcare providers are encouraged to report the adverse effect to the FDA.

Type 2 Diabetes Medication | BYETTA® (exenatide) injection

It may have direct beta-cell toxicity; the effects may be dose-related. The day of weekly administration can be changed if needed, as long as the last dose was administered 3 or more days before. The concurrent use of exenatide with prandial insulin has not been studied and cannot be recommended. Exenatide does not impair the normal glucagon response to hypoglycemia.

Blood glucose should be closely monitored.

Official BYETTA® (exenatide) injection Healthcare Professional Website

When used at daily doses of to 2, mg, niacin significantly lowers LDL cholesterol and triglycerides while increasing HDL cholesterol. Subcutaneous dosage extended-release once weekly injection suspension, Bydureon or Bydureon BCise.

Acetaminophen; Chlorpheniramine; Phenylephrine; Phenyltoloxamine: After initiation and dose increases of BYETTA, observe patients carefully for pancreatitis including persistent severe abdominal pain, sometimes radiating to the back, with or without vomiting.

Because acarbose has limited systemic absorption, which results in minimal maternal plasma concentrations, clinically significant exposure via breast milk is not expected.

Dehydration, dialysis, kidney transplant, renal disease, renal failure, renal impairment. Moderate In patients with diabetes mellitus, fluoxetine may alter glycemic control.

The clinical effects of these competing mechanisms are not known.